These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
506 related articles for article (PubMed ID: 6431411)
1. Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts. Collins T; Korman AJ; Wake CT; Boss JM; Kappes DJ; Fiers W; Ault KA; Gimbrone MA; Strominger JL; Pober JS Proc Natl Acad Sci U S A; 1984 Aug; 81(15):4917-21. PubMed ID: 6431411 [TBL] [Abstract][Full Text] [Related]
2. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts. Maurer DH; Hanke JH; Mickelson E; Rich RR; Pollack MS J Immunol; 1987 Aug; 139(3):715-23. PubMed ID: 3110281 [TBL] [Abstract][Full Text] [Related]
3. Induction of MHC class II molecules HLA-DR, -DP and -DQ and ICAM 1 in human podocytes by gamma-interferon. Baudeau C; Delarue F; Hé CJ; Nguyen G; Adida C; Peraldi MN; Sraer JD; Rondeau E Exp Nephrol; 1994; 2(5):306-12. PubMed ID: 7812737 [TBL] [Abstract][Full Text] [Related]
4. Nicotinamide and 3-aminobenzamide reduce interferon-gamma-induced class II MHC (HLA-DR and -DP) molecule expression on cultured human endothelial cells and fibroblasts. Otsuka A; Hanafusa T; Miyagawa J; Kono N; Tarui S Immunopharmacol Immunotoxicol; 1991; 13(3):263-80. PubMed ID: 1834724 [TBL] [Abstract][Full Text] [Related]
5. Effect of gamma interferon on HLA class-I and -II transcription and protein expression in human breast adenocarcinoma cell lines. Jabrane-Ferrat N; Faille A; Loiseau P; Poirier O; Charron D; Calvo F Int J Cancer; 1990 Jun; 45(6):1169-76. PubMed ID: 2112515 [TBL] [Abstract][Full Text] [Related]
6. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression. Geppert TD; Lipsky PE J Immunol; 1985 Dec; 135(6):3750-62. PubMed ID: 3934267 [TBL] [Abstract][Full Text] [Related]
7. Uncoordinate induction and differential regulation of HLA class-I and class-II expression by gamma-interferon in differentiating human neuroblastoma cells. Ponzoni M; Guarnaccia F; Corrias MV; Cornaglia-Ferraris P Int J Cancer; 1993 Nov; 55(5):817-23. PubMed ID: 8244579 [TBL] [Abstract][Full Text] [Related]
8. Effect of recombinant human leukocyte, fibroblast, and immune interferons on expression of class I and II major histocompatibility complex and invariant chain in early passage human melanoma cells. Nisticò P; Tecce R; Giacomini P; Cavallari A; D'Agnano I; Fisher PB; Natali PG Cancer Res; 1990 Dec; 50(23):7422-9. PubMed ID: 1701342 [TBL] [Abstract][Full Text] [Related]
9. Expression of class II-MHC antigens in the dermis of patients with progressive systemic sclerosis. Gruschwitz M; Sepp N; Kofler H; Wick G Immunobiology; 1991 Jun; 182(3-4):234-55. PubMed ID: 1833311 [TBL] [Abstract][Full Text] [Related]
10. Discoordinate surface expression of IFN-gamma-induced HLA class II proteins in nonprofessional antigen-presenting cells with absence of DM and class II colocalization. Muczynski KA; Anderson SK; Pious D J Immunol; 1998 Apr; 160(7):3207-16. PubMed ID: 9531276 [TBL] [Abstract][Full Text] [Related]
11. Immunochemical and functional analysis of HLA class II antigens induced by recombinant immune interferon on normal epidermal melanocytes. Tsujisaki M; Igarashi M; Sakaguchi K; Eisinger M; Herlyn M; Ferrone S J Immunol; 1987 Feb; 138(4):1310-6. PubMed ID: 3100635 [TBL] [Abstract][Full Text] [Related]
12. Recombinant human tumor necrosis factor increases mRNA levels and surface expression of HLA-A,B antigens in vascular endothelial cells and dermal fibroblasts in vitro. Collins T; Lapierre LA; Fiers W; Strominger JL; Pober JS Proc Natl Acad Sci U S A; 1986 Jan; 83(2):446-50. PubMed ID: 3455781 [TBL] [Abstract][Full Text] [Related]
13. A trans-acting class II regulatory gene unlinked to the MHC controls expression of HLA class II genes. de Préval C; Lisowska-Grospierre B; Loche M; Griscelli C; Mach B Nature; 1985 Nov 21-27; 318(6043):291-3. PubMed ID: 3934559 [TBL] [Abstract][Full Text] [Related]
14. Cytokine regulation of major histocompatibility complex antigen expression by human oral and skin keratinocytes. Li J; Farthing PM; Thornhill MH Arch Oral Biol; 1996 Jun; 41(6):533-8. PubMed ID: 8937643 [TBL] [Abstract][Full Text] [Related]
15. Regulation of genes for HLA class II antigens in cell lines from patients with severe combined immunodeficiency. de Préval C; Hadam MR; Mach B N Engl J Med; 1988 May; 318(20):1295-300. PubMed ID: 3129659 [TBL] [Abstract][Full Text] [Related]
16. Patterns of constitutive and IFN-gamma inducible expression of HLA class II molecules in human melanoma cell lines. Rodríguez T; Méndez R; Del Campo A; Aptsiauri N; Martín J; Orozco G; Pawelec G; Schadendorf D; Ruiz-Cabello F; Garrido F Immunogenetics; 2007 Feb; 59(2):123-33. PubMed ID: 17180681 [TBL] [Abstract][Full Text] [Related]
17. HLA-DR synthesis induction and expression in HLA-DR-negative carcinoma cell lines of diverse origins by interferon-gamma but not by interferon-beta. Shaw AR; Chan JK; Reid S; Seehafer J J Natl Cancer Inst; 1985 Jun; 74(6):1261-8. PubMed ID: 3923246 [TBL] [Abstract][Full Text] [Related]
18. Interactions of T lymphocytes with human vascular endothelial cells: role of endothelial cells surface antigens. Pober JS; Gimbrone MA; Collins T; Cotran RS; Ault KA; Fiers W; Krensky AM; Clayberger C; Reiss CS; Burakoff SJ Immunobiology; 1984 Dec; 168(3-5):483-94. PubMed ID: 6397428 [TBL] [Abstract][Full Text] [Related]
19. Regulation of HLA-DR and invariant chain expression by human peripheral blood mononuclear cells with lead, interferon-gamma, or interleukin-4. Guo TL; Mudzinski SP; Lawrence DA Cell Immunol; 1996 Jul; 171(1):1-9. PubMed ID: 8660831 [TBL] [Abstract][Full Text] [Related]
20. MHC class II antigen expression in human vascular smooth muscle cells is induced by interferon-gamma and modulated by tumour necrosis factor and lymphotoxin. Stemme S; Fager G; Hansson GK Immunology; 1990 Feb; 69(2):243-9. PubMed ID: 2106484 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]